Governing medical tourism in Asia: comparative policy evidence and implications for China

When a person travels to another country to receive medical treatment, they are stepping into a complex web of responsibilities that rarely fits neatly within a single set of rules. This practice, known as medical tourism, is not merely a vacation with a doctor's appointment; it is a cross-border exchange where a patient leaves their home, enters a new legal system, receives care, and then returns home, often carrying the consequences of that care with them. The central challenge in this field is not just whether the treatment works, but who is responsible for what at every step of the journey. Who ensures the patient understands the risks? Who pays if something goes wrong? And how does a hospital in one country coordinate with an insurance company or a doctor in another? As countries in Asia increasingly market their healthcare services to international visitors, the question of how to govern these interactions has become urgent. Without clear answers, patients may find themselves in a gap where no single institution accepts full accountability for their safety or their bill.

A team of researchers set out to map how different Asian nations handle these responsibilities. They did not simply count how many tourists arrived or how much money was spent; instead, they examined the official documents, laws, and guidelines that govern the system. Their goal was to trace the path of a patient from the moment they decide to travel until they return home, looking specifically at who holds the authority and who bears the burden of care at each transition. They focused on five established destinations—Japan, South Korea, Singapore, Thailand, and India—and compared them with two emerging initiatives in China: a coordinated program in Shanghai and a special policy zone in Boao Lecheng. By reading the fine print of government strategies, hospital accreditation rules, and visa requirements, the researchers built a picture of how these systems actually function on paper, and where the gaps in accountability might lie.

The investigation revealed that no two countries organize these responsibilities in the same way. In Japan, the system is built around a chain of coordination. A patient seeking a medical stay visa must provide documentation of their planned care and link up with a registered guarantor. This arrangement connects the immigration process with the proposed treatment, but the guarantor's role is administrative; they do not take responsibility for clinical complications. The country also has a specific accreditation body that checks if hospitals can properly receive foreign patients, focusing on language support and cultural sensitivity, while a separate organization provides a directory of hospitals and estimated costs. These pieces work together, but they are managed by different groups, meaning a patient might navigate a visa officer, a reception service, and a hospital, each with a different scope of duty.

South Korea takes a different approach by tying the right to recruit patients directly to strict obligations. To serve international visitors, a hospital must carry medical malpractice liability insurance and register with a specific government program. The country tracks its foreign patient numbers closely, reporting over one million visits in a single year, but the researchers noted that these figures include many repeat visits and do not necessarily reflect a unique count of individuals. The system is designed to ensure that if a hospital accepts a foreign patient, it has a financial safety net in place, yet the researchers found that the impact of this growth on the local population's access to care remains unclear.

Singapore offers a sharp contrast by drawing a hard line around its public hospitals. The government has explicitly stated that public healthcare institutions are not allowed to actively market themselves to foreign patients. This policy protects the domestic mandate of public hospitals, ensuring that their primary focus remains on local residents. While private hospitals in Singapore are free to recruit international clients, the public sector remains a closed loop for domestic care. This distinction highlights a deliberate choice to separate the business of attracting tourists from the duty of providing public health services.

Thailand presents a more blended picture, where medical care, wellness, and tourism are often promoted together. The government coordinates efforts between health authorities and tourism boards, creating a "medical hub" that includes everything from surgery to wellness retreats. However, this blending creates confusion about responsibility. A hospital might be accredited for its clinical procedures, while a separate wellness award certifies its spa services, but these two standards do not necessarily overlap. Furthermore, the country's statistics often mix medical tourists with expatriates and long-term residents, making it difficult to know exactly how many people are traveling specifically for treatment. The researchers found that while the promotional machinery is robust, the specific rules for who handles a complication after a patient leaves the country are not always clear.

India relies on a national strategy that brings together ministries of health, tourism, and immigration to coordinate the sector. The system involves a national board, accreditation agencies, and visa processes that require a letter from the receiving hospital. This top-down approach attempts to create a unified pathway for patients, linking entry visas to specific providers. However, the researchers observed that while the government sets the stage, the actual relationships between hospitals, insurance companies, and facilitators are complex and often operate in the background. The national plan does not guarantee that every patient has a seamless experience or that insurance coverage is consistent across the board.

When the researchers turned their attention to China, they found two distinct models in the making. Shanghai has launched a pilot program involving public hospitals, with a government plan that outlines responsibilities for insurance cooperation, complaint handling, and statistical monitoring. The city reports thousands of foreign inpatients, but the data does not yet distinguish between people traveling specifically for care and those who are already living in the region. The policy design is there, but the researchers noted that it remains to be seen how these responsibilities are coordinated in practice and whether the international services are displacing care for local residents.

In Boao Lecheng, a special zone in Hainan, the focus is on access to imported medical technologies and drugs that are not yet available elsewhere in China. This area operates under a different set of rules, allowing for the use of advanced treatments under specific regulatory permissions. The zone has reported hundreds of thousands of visits, but these numbers represent episodes of care or visits, not unique patients traveling from abroad. The regulations here are very specific about the technologies allowed and the oversight required, but they apply only to this narrow scope. The researchers pointed out that while the zone is a laboratory for new medical access, it does not yet provide a complete picture of how a full medical tourism journey is managed from start to finish.

The core finding of the study is that while these Asian destinations have created various tools to manage international patients, none of them have fully solved the problem of continuity and accountability. The documents show who is supposed to do what, but they do not prove that these arrangements work smoothly when a patient returns home. For instance, a hospital might have a clear process for discharging a patient, but there is often no evidence in the public records that the patient's home doctor receives the medical records or that a follow-up plan is in place. Similarly, while some countries require liability insurance, the researchers could not find evidence that this insurance covers complications that arise after the patient has left the country.

The study also challenges the idea that a large number of visitors or a strong promotional campaign means the system is safe or effective. A country might have a sophisticated visa process or a high number of foreign patients, but if the rules do not clearly define who is responsible for a complication after the patient departs, the system remains incomplete. The researchers emphasized that the existence of a policy does not mean it is being implemented effectively, nor does it mean that the domestic healthcare system is not being affected by the influx of international patients.

For China, the researchers suggest that the priority is not simply to promote more medical tourism, but to clarify the rules. They recommend that the country distinguish between different types of patients in its data, so that policymakers can see exactly who is traveling for care. They also suggest that the existing safeguards in Shanghai and Boao Lecheng need to be tested to see if they actually protect patients and if they coordinate well with the healthcare systems back home. The study concludes that without clear evidence of how responsibilities are shared between providers, insurers, and jurisdictions, the growth of medical tourism in China and across Asia will remain a question of potential rather than a proven success in patient safety. The path forward requires looking beyond the numbers of visitors and focusing on the details of care that happen after the patient leaves the hospital.